Realbotix Reports Financial Results for Q1-2025
Realbotix (XBOTF) reported strong Q1-2025 financial results, with total revenue increasing 419% to $858k compared to Q1-2024. The company achieved a net income of $918,324 and increased its total digital assets and cash by 8% to $10.6 million.
Key developments include the TSXV's approval of a Normal Course Issuer Bid allowing the purchase of up to 9,797,779 Common Shares, a partnership with Compass UOL including a $100,000 AWS subsidy, and the launch of a new customer-focused website. The company unveiled its latest humanoid robot, Melody, at CES 2025, generating over 4 billion media impressions.
Realbotix also received approximately $1.01M from Genesis, representing 40% of their SOL claim, and 222.2 ETH (77% of ETH claim). The company announced integration capabilities with major LLMs including ChatGPT, Llama, Gemini, and DeepSeek R1.
Realbotix (XBOTF) ha riportato risultati finanziari solidi per il Q1-2025, con un aumento del fatturato totale del 419% a $858k rispetto al Q1-2024. L'azienda ha raggiunto un reddito netto di $918,324 e ha aumentato i suoi beni digitali totali e la liquidità dell'8% a $10,6 milioni.
Sviluppi chiave includono l'approvazione da parte del TSXV di un Normal Course Issuer Bid che consente l'acquisto di fino a 9.797.779 azioni ordinarie, una partnership con Compass UOL che prevede un sussidio AWS di $100.000 e il lancio di un nuovo sito web orientato al cliente. L'azienda ha presentato il suo ultimo robot umanoide, Melody, al CES 2025, generando oltre 4 miliardi di impressioni sui media.
Realbotix ha anche ricevuto circa $1,01 milioni da Genesis, che rappresenta il 40% della loro richiesta SOL, e 222,2 ETH (77% della richiesta ETH). L'azienda ha annunciato capacità di integrazione con i principali LLM, tra cui ChatGPT, Llama, Gemini e DeepSeek R1.
Realbotix (XBOTF) reportó resultados financieros sólidos para el Q1-2025, con un aumento del ingreso total del 419% a $858k en comparación con el Q1-2024. La empresa logró un ingreso neto de $918,324 y aumentó sus activos digitales totales y efectivo en un 8% a $10.6 millones.
Los desarrollos clave incluyen la aprobación por parte de TSXV de una oferta de compra normal que permite la adquisición de hasta 9,797,779 acciones ordinarias, una asociación con Compass UOL que incluye un subsidio de AWS de $100,000 y el lanzamiento de un nuevo sitio web enfocado en el cliente. La empresa presentó su último robot humanoide, Melody, en CES 2025, generando más de 4 mil millones de impresiones en los medios.
Realbotix también recibió aproximadamente $1.01 millones de Genesis, representando el 40% de su reclamo SOL, y 222.2 ETH (77% del reclamo ETH). La empresa anunció capacidades de integración con los principales LLMs, incluyendo ChatGPT, Llama, Gemini y DeepSeek R1.
Realbotix (XBOTF)는 Q1-2025에 강력한 재무 실적을 보고했으며, 총 수익이 Q1-2024에 비해 419% 증가하여 858,000달러에 달했습니다. 회사는 918,324달러의 순이익을 달성했으며, 총 디지털 자산과 현금을 8% 증가시켜 1,060만 달러에 이르렀습니다.
주요 개발 사항으로는 TSXV의 정상적인 발행자 입찰 승인, 최대 9,797,779주를 구매할 수 있는 권한, AWS 보조금 10만 달러를 포함한 Compass UOL과의 파트너십, 고객 중심의 새로운 웹사이트 출범이 있습니다. 회사는 CES 2025에서 최신 휴머노이드 로봇 Melody를 공개하며 40억 건 이상의 미디어 노출을 생성했습니다.
Realbotix는 또한 Genesis로부터 약 101만 달러를 받았으며, 이는 그들의 SOL 청구의 40%에 해당하고, 222.2 ETH (ETH 청구의 77%)를 포함합니다. 회사는 ChatGPT, Llama, Gemini 및 DeepSeek R1과 같은 주요 LLM과의 통합 기능을 발표했습니다.
Realbotix (XBOTF) a annoncé de solides résultats financiers pour le Q1-2025, avec une augmentation du chiffre d'affaires total de 419% à 858 000 $ par rapport au Q1-2024. L'entreprise a réalisé un revenu net de 918 324 $ et a augmenté ses actifs numériques totaux et sa trésorerie de 8 % pour atteindre 10,6 millions de dollars.
Les développements clés comprennent l'approbation par le TSXV d'une offre normale d'achat permettant l'acquisition de jusqu'à 9 797 779 actions ordinaires, un partenariat avec Compass UOL incluant une subvention AWS de 100 000 $ et le lancement d'un nouveau site Web axé sur le client. L'entreprise a dévoilé son dernier robot humanoïde, Melody, au CES 2025, générant plus de 4 milliards d'impressions médiatiques.
Realbotix a également reçu environ 1,01 million de dollars de Genesis, représentant 40 % de leur demande SOL, et 222,2 ETH (77 % de la demande ETH). L'entreprise a annoncé des capacités d'intégration avec les principaux LLM, y compris ChatGPT, Llama, Gemini et DeepSeek R1.
Realbotix (XBOTF) hat starke Finanzzahlen für das Q1-2025 berichtet, mit einem Anstieg des Gesamtumsatzes um 419% auf 858.000 USD im Vergleich zum Q1-2024. Das Unternehmen erzielte einen Nettogewinn von 918.324 USD und erhöhte seine gesamten digitalen Vermögenswerte und Bargeld um 8% auf 10,6 Millionen USD.
Wichtige Entwicklungen umfassen die Genehmigung durch die TSXV für ein Normal Course Issuer Bid, das den Kauf von bis zu 9.797.779 Stammaktien ermöglicht, eine Partnerschaft mit Compass UOL, die einen AWS-Zuschuss von 100.000 USD umfasst, und den Start einer neuen kundenorientierten Website. Das Unternehmen stellte seinen neuesten humanoiden Roboter, Melody, auf der CES 2025 vor und generierte über 4 Milliarden Medienimpressionen.
Realbotix erhielt auch etwa 1,01 Millionen USD von Genesis, was 40% ihres SOL-Anspruchs entspricht, sowie 222,2 ETH (77% des ETH-Anspruchs). Das Unternehmen kündigte Integrationsmöglichkeiten mit wichtigen LLMs wie ChatGPT, Llama, Gemini und DeepSeek R1 an.
- 419% revenue increase to $858k in Q1-2025
- Net income of $918,324
- 8% increase in digital assets and cash to $10.6M
- Secured $100,000 AWS subsidy
- Recovery of $1.01M from Genesis (40% of SOL claim) and 222.2 ETH (77% of ETH claim)
- None.
Q1-2025 Financial and Operating Highlights
-
419% increase in total revenue to$858 k-
Total revenue for the trailing 6 months, a non-IFRS measure, which comprises total revenue for Q4-2024 and Q1-2025, was
$1.6M
-
Total revenue for the trailing 6 months, a non-IFRS measure, which comprises total revenue for Q4-2024 and Q1-2025, was
-
Q1-2025 Net income of
$918,324 -
8% increase in total digital assets and cash to$10.6 million CAD , from September 30, 2024. Digital asset values are as of December 31, 2024.$15.3 million - On October 16, 2024, the Company announced that the TSXV approved its notice to implement a “Normal Course Issuer Bid” (“NCIB”) providing the Company the option to purchase, and subsequently cancel, up to 9,797,779 of its Common Shares.
-
On December 16, 2024, Realbotix announced partnership with Compass UOL, a global leader in digital transformation services, and secured a
$100,000 - On December 17, 2024, Realbotix announced the launch of its new customer-focused website, www.realbotix.com. This site is designed to provide customers with product details, costs, and ordering information, while www.realbotix.ai will continue to serve as the hub for investors and corporate news.
- On January 7, 2025, Realbotix unveiled its latest humanoid robot, Melody, at the 2025 Consumer Electronics Show (“CES”). Melody is an open-source robot designed with upgraded features to improve functionality, adaptability, and user experience.
- Realbotix’s presence at CES 2025 generated significant media attention, with over 4 billion global media impressions recorded to date and over 1,000 articles including from outlets such as Forbes, CBS, CNET and Barstool Sports.
-
Through the course of 2024 and into 2025, based on the reduced claims after the loan set-off, the Company has received from Genesis approximately
$1.01M 40% of our SOL claim, and 222.2 ETH, representing77% of our ETH claim. - On February 4th, Realbotix announced that its robotic hardware platform will integrate 3rd party LLMs such as OpenAI’s ChatGPT, Meta’s Llama, Google’s Gemini and the newly launched DeepSeek R1. Realbotix’s ability to integrate a variety of third party AI platforms provides an additional level of customizations to its robotic platform.
“Q1 2025 is the first complete reported quarter since we rebranded as Realbotix and expanded our product lines to include robotics and AI,” said Andrew Kiguel, CEO of Realbotix. “Our focus in 2025 is on building the business, showcasing our robots and AI, establishing partnerships for the future, and having meaningful acceleration of sales. We thank shareholders for their trust in management and the business.”
A complete financial reporting package, including the Interim Financial Statements and Management’s Discussion & Analysis, is available on the SEDAR+ website (www.sedarplus.ca).
An investor call has been scheduled to discuss the Company’s Q1-2025 financial results, hosted by CEO Andrew Kiguel, starting at 4:00 pm ET on February 18, 2025.
Conference Call Details:
Date: February 18, 2025
Time: 4:00 pm ET
Zoom Webinar Registration:
https://us06web.zoom.us/webinar/register/WN_DOTwsO_nSaKgmhBi1kqsHg
To join the webinar, register using the link provided above. Upon registration, a Zoom link will be emailed to the registered email address. The webinar will be available via computer, tablet, and smartphone devices. In addition, a dial-in phone number will be provided in the email upon registration. Callers dialing in using a telephone will automatically be placed in a listen-only mode. The question period will not be available to dial-in callers.
About Realbotix
Transcending the barrier between man and machine, Realbotix creates customizable, full-bodied, humanoids with AI integration that improve the human experience through connection, learning and play. Manufactured in the
Realbotix sells humanoid products with embedded AI and vision systems that enable human-like social interactions and intimate connections with humans. Our integration of hardware and AI software results in the most human looking full-sized robots on this planet. We achieve this through patented technologies that deliver human-like appearance and movements. This versatility makes our robots and their personalities customizable and programmable to suit a wide variety of use cases.
Realbotix.AI: Corporate and Investor site.
Realbotix.com: Robotix Customer site.
Keep up-to-date on Realbotix developments by joining our online communities on Twitter, LinkedIn, and YouTube.
Follow Aria, our humanoid robot, on Instagram and TikTok.
Forward-Looking Statements
This news release includes certain forward-looking statements as well as management’s objectives, strategies, beliefs and intentions. Forward looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, as described in more detail in our securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Non-IFRS Measures and Reconciliation
This press release includes certain financial measures that are not recognized under IFRS and do not have a standardized meaning prescribed by IFRS. These Non-IFRS financial measures may not be comparable to similar measures presented by other companies. Management believes that these measures provide useful information to investors by offering additional insights into financial and operational performance.
The following Non-IFRS measure is included in this press release:
- Total Revenue for the trailing 6 months – This measure represents the sum of total revenue reported in Q4-2024 and Q1-2025. It is presented to highlight the company’s two full quarterly revenues since the acquisition of Simulacra Corp.
Management uses this metric to assess new revenue from recently acquired business. However, this measure should not be considered in isolation or as a substitute for IFRS-reported revenue.
Reconciliation of Non-IFRS Measures to IFRS Measures
The table below provides a reconciliation of total revenue for Q4-2024 and Q1-2025 (Non-IFRS) to its most directly comparable IFRS financial measure:
Measure |
Amount ($) |
Q4-2024 Revenue (IFRS) |
|
Q1-2025 Revenue (IFRS) |
|
Total revenue for Q4-2024 and Q1-2025 (Non-IFRS) |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250213723601/en/
Andrew Kiguel, CEO
Email: contact@realbotix.com
Jennifer Karkula, Head of Communications
Email: contact@realbotix.com
Telephone: 647-578-7490
Source: Realbotix Corp.
FAQ
What was Realbotix (XBOTF) revenue growth in Q1-2025?
How much did Realbotix (XBOTF) receive from the Genesis claim settlement?
What AI platforms will Realbotix (XBOTF) integrate into its robotic hardware?
How many shares can Realbotix (XBOTF) purchase under its Normal Course Issuer Bid?
What was Realbotix (XBOTF) net income for Q1-2025?
